GSK股價下跌，法院裁決Zantac訴訟繼續進行

Reported 6 months ago

GSK股價在法院裁定70,000多宗訴訟指控心口痛藥Zantac可能導致癌症後下滑，即將進入周一開盤交易。雖然GSK今年表現良好，但此次訴訟可能帶來財務壓力。股票下跌，但分析師對GSK仍持積極態度。

You may also interested in these wikis

Billionaire Hedge Fund Manager Diversifies Portfolio, Sells Nvidia and Palantir for Archer Aviation

Hesai Aims for Lidar Technology to Be as Ubiquitous as Airbags

3 Promising Tech Stocks to Purchase Now

UBS: Tesla Stock Surge Fueled by Sentiment, Not Fundamentals

Implications of Amazon's Robot Expansion on Warehouse Workers

HP Reports Q4 Earnings: CEO Lores Discusses AI PCs and Tariffs

Consumer Confidence Rises While New Home Sales Decline in October

Federal court dismisses defamation lawsuit against Fox News for Jan. 6 conspiracy theory

Has Nvidia Stock Peaked? A Key Metric Signals Possible Decline.

Investors Anticipate Positive Market Trends in 2025

Back to all Wikis